Mollugin as a Plant‐Derived Bioactive: Preclinical Pharmacology, Structure–Activity Relationships, Pharmacokinetic Evidence and Safety Requirements for Food–Health Translation
Mollugin is a naturally occurring naphthopyran compound isolated from Rubia cordifolia L. and other medicinal plants. Its diverse biological activities have attracted research interest, particularly in cancer‐related experimental models. This narrative review critically examines the phytochemistry, structure–activity relationships, preclinical pharmacology, pharmacokinetics, and toxicological evidence of mollugin, with emphasis on its potential relevance to food–health applications. Available pharmacological evidence is predominantly derived from in vitro studies and a limited number of animal models. Experimental findings indicate that mollugin modulates apoptosis, autophagy, ferroptosis, and signaling pathways associated with cell proliferation, survival, and drug resistance, including PI3K/Akt/mTOR, NF‐κB, HER2/Akt, and Notch‐related signaling. However, these observations do not establish clinical efficacy or direct molecular target specificity. Pharmacokinetic studies have quantified systemic exposure to mollugin following oral administration of multicomponent Rubia cordifolia preparations, but the absolute oral bioavailability of purified mollugin remains undetermined. Furthermore, available toxicological investigations are insufficient to establish a comprehensive safety profile or a safe dietary exposure range. Important evidence gaps include repeated‐dose toxicity, genotoxicity, reproductive and developmental toxicity, metabolic disposition, and potential interactions. No controlled human evidence currently supports the clinical efficacy or safety of mollugin. Consequently, its application as a functional‐food or nutraceutical ingredient remains hypothetical and requires rigorous evaluation of botanical quality, oral exposure, pharmacokinetics, and toxicological safety. Overall, mollugin represents a compound of preclinical pharmacological interest whose potential food–health applications require further experimental validation.
Authors
- Daniela Cornelia Călina (ORCID: https://orcid.org/0000-0002-1523-9116)
- William N. Setzer (ORCID: https://orcid.org/0000-0002-3639-0528)
- Javad Sharifi‐Rad (ORCID: https://orcid.org/0000-0002-7301-8151)
- Ipek Peşin Süntar (ORCID: https://orcid.org/0000-0003-4201-1325)
- Hasya Nazlı Gök (ORCID: https://orcid.org/0000-0003-4115-7509)
- Mert İlhan (ORCID: https://orcid.org/0000-0001-5042-3915)
Institutions
- University of Medicine and Pharmacy of Craiova (RO)
- Universidad Espíritu Santo (EC)
- Aromatic Plant Research Center (US)
- Centro de Estudios Tecnológicos y Universitarios del Golfo (MX)
- Düzce Üniversitesi (TR)
- University of Alabama in Huntsville (US)
- Gazi University (TR)
Publication Details
- Journal
- Food Safety and Health
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1002/fsh3.70132
- Primary Topic
- Medicinal Plant Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00